To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

MedImmune Inc.

(MEDI)

Eric Hecht of Morgan Stanley reiterated

Read the full 91 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE